In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...